Poster: ABCL-396: Incidence, Onset, and Management of Edema and Effusion in Patients Treated with Loncastuximab Tesirine for R/R DLBCL in the LOTIS Clinical Trial Program

Journal article

Peer reviewed

Juan Pablo Alderuccio, Kirit Ardeshna, Brian Hess, John Radford, Matt Lunning, David Ungar, Muneet Burke, Luqiang Wang and Melhem Solh

Clinical lymphoma, myeloma and leukemia, Vol.21, pp.S238-S238

2021-09

Metrics

6 Record Views

Title: Poster: ABCL-396: Incidence, Onset, and Management of Edema and Effusion in Patients Treated with Loncastuximab Tesirine for R/R DLBCL in the LOTIS Clinical Trial Program
Creators: Juan Pablo Alderuccio - University of Miami
Kirit Ardeshna - University College London Hospitals NHS Foundation Trust
Brian Hess - Medical University of South Carolina
John Radford - University of Manchester
Matt Lunning - University of Nebraska Medical Center
David Ungar - Adc Therapeutics
Muneet Burke - Adc Therapeutics
Luqiang Wang - Adc Therapeutics
Melhem Solh - Northside Hospital
Publication Details: Clinical lymphoma, myeloma and leukemia, Vol.21, pp.S238-S238
Publisher: Elsevier Inc
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031713446202976